• Mashup Score: 8

    Exploring potential pathways for development of imaging endpoints for clinical trials in AL and ATTR amyloidosis.

    Tweet Tweets with this article
    • An exciting session at #AmyloidosisForum begins now, hearing from multiple departments at FDA, with representatives from EMA and MHRA as well, sharing the regulatory perspective on imaging and #amyloidosis from around the world. Watch online: https://t.co/Ck8RIbmUzm https://t.co/DS1RyffBIQ

    • Happening Now: the second half of our sessions for the #AmyloidosisForum, including lively discussions outlining how imaging can be used in clinical outcomes for #amyloidosis, moderated by Preston Dunnmon Watch online here: https://t.co/Ck8RIbmUzm https://t.co/2Jl9AgwBmv

  • Mashup Score: 0

    Exploring potential pathways for development of imaging endpoints for clinical trials in AL and ATTR amyloidosis.

    Tweet Tweets with this article
    • The #AmyloidosisForum is taking a break for lunch, but we'll see everyone at 1:05pm ET for the second half of our sessions, examining pathways to qualifying imaging for #amyloidosis clinical trials, moderated by Preston Dunnmon. Watch online here: https://t.co/Ck8RIbmUzm https://t.co/KRRTNAscGq

  • Mashup Score: 0

    Exploring potential pathways for development of imaging endpoints for clinical trials in AL and ATTR amyloidosis.

    Tweet Tweets with this article
    • Join us today for the #AmyloidosisForum, exploring the different imaging modalities currently being used in AL/ATTR #amyloidosis. 30 + speakers, 20+ institutions, 10+ sessions, 1 goal. It’s not too late, register to watch online: https://t.co/Ck8RIbmUzm https://t.co/OovMfEtOlc

  • Mashup Score: 0

    https://amyloidosisforum.org/imaging-as-surrogate-endpoints/ A Road to Implementation of Imaging as Surrogate Endpoints for Studies in AL and ATTR Amyloidosis Join us for this hybrid in-person and…

    Tweet Tweets with this article
    • Join us today for Imaging As Surrogate Endpoints. This hybrid in-person and virtual meeting of the #AmyloidosisForum will explore the different imaging modalities currently being used in AL/ATTR #amyloidosis. It’s not too late, register to watch online: https://t.co/Ho13DgZzZf https://t.co/Azto5RhYEM

  • Mashup Score: 0

    Exploring potential pathways for development of imaging endpoints for clinical trials in AL and ATTR amyloidosis.

    Tweet Tweets with this article
    • The #AmyloidosisForum is tomorrow, hosted by @US_FDA! Excited to have @i_lousada, @radigun1, @DorbalaSharmila, Preston Dunnmon and 30+ speakers discussing Pathways for Development of Imaging Endpoints for Clinical Trials in AL and ATTR #amyloidosis: https://t.co/Ck8RIbEvqU https://t.co/Da7gh80cUc

  • Mashup Score: 1

    Exploring how imaging is being used in AL/ATTR amyloidosis and identifying challenges to use as endpoints in interventional clinical trials

    Tweet Tweets with this article
    • Patients are at the heart of everything we do. That's why we're glad to have our Founder & CEO, @i_lousada, share her story with imaging & #amyloidosis at the #AmyloidosisForum on Friday, as well as what we've learned from our recent patient poll. https://t.co/zdFhgHIeRP https://t.co/LGe9uf4C36

  • Mashup Score: 2

    Exploring how imaging is being used in AL/ATTR amyloidosis and identifying challenges to use as endpoints in interventional clinical trials

    Tweet Tweets with this article
    • Very excited to have @MasriAhmadMD presenting a case study detailing the role of imaging in the approval of Mavacamten in oHCM at this Friday's #AmyloidosisForum. Sure to prompt great discussion regarding the use of imaging in #amyloidosis studies: https://t.co/zdFhgHIeRP https://t.co/2E5MdgClUD